A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT07162597
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT07162597
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07162597. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-01 (anticipated); primary completion 2028-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava
- Condition
- Atrial Fibrillation (Paroxysmal)
- Intervention (Device)
- Pulsed Field Ablation
- Lead sponsor
- Shanghai Zhongshan Hospital
- Collaborator
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct07162597- Content hash
9bfcb9095098fe6a6e0c507bb183a87bf3823f103bb0d0c106d00d1f7a6a59e1